Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Colorcon
Moodys
Federal Trade Commission
McKesson
Express Scripts
US Department of Justice
Dow

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200565

« Back to Dashboard

NDA 200565 describes PHENYTOIN, which is a drug marketed by Actavis Mid Atlantic, Taro, Vistapharm, Wockhardt Bio Ag, Epic Pharma Llc, Mylan Pharms Inc, Aurobindo Pharma Ltd, Pharmeral, Watson Labs, Acella Pharms Llc, Fresenius Kabi Usa, Hospira, Luitpold, Marsam Pharms Llc, Smith And Nephew, Solopak, Warner Chilcott, and West-ward Pharms Int, and is included in twenty-four NDAs. It is available from twelve suppliers. Additional details are available on the PHENYTOIN profile page.

The generic ingredient in PHENYTOIN is phenytoin sodium. There are twenty drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
Summary for 200565
Tradename:PHENYTOIN
Applicant:Taro
Ingredient:phenytoin
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 200565
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENYTOIN phenytoin TABLET, CHEWABLE;ORAL 200565 ANDA Taro Pharmaceuticals U.S.A., Inc 51672-4146 N 51672-4146-1
PHENYTOIN phenytoin TABLET, CHEWABLE;ORAL 200565 ANDA Taro Pharmaceuticals U.S.A., Inc 51672-4146 N 51672-4146-3

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength50MG
Approval Date:Apr 17, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Fuji
AstraZeneca
Medtronic
Chinese Patent Office
Merck
Harvard Business School
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.